Pancreatic Cancer Research

Clinical trialObservationalUnknown

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Outcome
Outcome unknown
Phase
Observational
Status
Unknown
Study type
Observational
Start
26 October 2021
Listed end
October 2025
Enrollment
20,000 participants
Sites
1
Primary outcomes
Biospecimen & Clinical Data Collection
Sponsor type
Industry
Results posted
No
Last update
7 May 2024

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.